What are the differential diagnoses for isolated asymptomatic thrombocytopenia in a child?

Differential Diagnosis of Asymptomatic Thrombocytopenia in Children

Primary Immune Thrombocytopenia (ITP)

Primary ITP is the most common cause of isolated thrombocytopenia in otherwise healthy children, typically affecting ages 1–7 years, often following viral infections, with two-thirds recovering spontaneously within 6 months. 1, 2

• The diagnosis requires isolated thrombocytopenia (platelet count <100 × 10⁹/L) with normal hemoglobin, white blood cell count, and peripheral smear showing normal-sized or mildly enlarged platelets. 1, 2
• Physical examination must be normal except for bleeding manifestations; any splenomegaly, hepatomegaly, or lymphadenopathy excludes primary ITP. 1
• Intracranial hemorrhage risk is extremely low (0.1–0.5%), and serious bleeding occurs in only 3% of children. 1, 2

Inherited Thrombocytopenias

Familial thrombocytopenias should be suspected when thrombocytopenia has been present since early life, a positive family history exists, or characteristic platelet morphology is identified. 3

• Bernard-Soulier syndrome presents with giant platelets approaching red blood cell size on peripheral smear and is frequently misdiagnosed as ITP. 4
• MYH9-related disease shows leukocyte inclusion bodies on peripheral smear, giant platelets, and may include hearing loss or renal abnormalities. 1
• Wiskott-Aldrich syndrome presents with small platelets, eczema, and recurrent infections. 1
• Thrombocytopenia-absent radius (TAR) syndrome is associated with bilateral radial aplasia and skeletal abnormalities. 5
• 22q11.2 deletion syndrome causes characteristically lower platelet counts with large platelets and reduced platelet quality. 1

Secondary Immune Thrombocytopenia

Autoimmune Disorders

• Systemic lupus erythematosus (SLE) presents with thrombocytopenia plus additional autoimmune features such as malar rash, oral ulcers, arthritis, or renal involvement; screen with ANA testing. 3, 2
• Antiphospholipid syndrome (APS) causes immune-mediated platelet destruction; requires testing for lupus anticoagulant, anticardiolipin antibodies, and anti-β2-glycoprotein I antibodies, confirmed on two occasions 12 weeks apart. 6, 2
• Common variable immunodeficiency (CVID) should be suspected with recurrent infections; measure quantitative immunoglobulin levels (IgG, IgA, IgM). 3, 2
• Autoimmune lymphoproliferative syndrome (ALPS) presents with persistent thrombocytopenia, lymphoproliferation, and recurrent infections. 3, 2

Infectious Causes

• HIV infection can cause thrombocytopenia that is clinically indistinguishable from primary ITP and may precede other manifestations by years; HIV antibody testing is mandatory in all children with risk factors. 1, 2
• Hepatitis C virus causes secondary ITP that may resolve with antiviral therapy; HCV serology should be obtained in adolescents with risk factors. 1, 2
• Helicobacter pylori eradication can normalize platelet counts in endemic regions; testing is not routinely recommended in children except in high-prevalence areas. 1, 2
• Perinatal cytomegalovirus infection should be considered when thrombocytopenia is recognized during the neonatal period. 7

Bone Marrow Disorders

Bone marrow examination is mandatory when abnormalities exist beyond isolated thrombocytopenia, including unexplained anemia, leukopenia, leukocytosis, or abnormal peripheral smear findings. 3, 1

• Acute leukemia presents with additional cytopenias, immature white cells (blasts) on peripheral smear, and systemic symptoms such as fever, bone pain, or weight loss. 3, 5
• Myelodysplastic syndromes are rare in children but should be excluded in patients older than 10 years with persistent thrombocytopenia and no response to ITP therapy. 3, 1
• Aplastic anemia produces pancytopenia without lymphadenopathy or organomegaly; bone marrow shows hypocellularity. 1
• Transient abnormal myelopoiesis associated with Down syndrome can present with neonatal thrombocytopenia. 7

Splenic Sequestration and Portal Hypertension

• Portal hypertension with hypersplenism causes platelet sequestration; the degree of thrombocytopenia correlates with splenomegaly magnitude. 1, 7
• Chronic liver disease reduces thrombopoietin production and causes direct bone marrow suppression; approximately 80% of cirrhotic patients have platelet counts below normal. 1

Drug-Induced Thrombocytopenia

• Medication-induced thrombocytopenia can occur with antibiotics (sulfonamides, vancomycin), anticonvulsants, NSAIDs, and heparin; a thorough medication history including over-the-counter products and herbal supplements is essential. 1
• Heparin-induced thrombocytopenia (HIT) typically presents 5–10 days after heparin exposure with moderate thrombocytopenia and paradoxical thrombosis risk; calculate the 4T score immediately if any heparin exposure occurred within 3 months. 1

Other Causes

• Cutaneous mastocytosis can present with isolated thrombocytopenia and should be considered when skin lesions are present. 7
• May-Hegglin anomaly shows characteristic Döhle-like inclusion bodies in leukocytes and giant platelets on peripheral smear. 7
• Gestational thrombocytopenia is the most common cause in pregnant adolescents, typically with platelet counts >70,000/µL. 1

Essential Diagnostic Algorithm

Step 1: Confirm True Thrombocytopenia

• Repeat platelet count in citrate or heparin tube to exclude EDTA-dependent pseudothrombocytopenia, which occurs in approximately 0.1% of samples. 1
• Obtain manual peripheral blood smear review by a hematopathologist; automated counters miss pseudothrombocytopenia, giant platelets, and schistocytes. 1

Step 2: Verify Isolated Thrombocytopenia

• Complete blood count with differential must show normal hemoglobin and white blood cell count; any additional cytopenias mandate immediate bone marrow examination. 1, 2

Step 3: Peripheral Smear Evaluation

• Normal-sized or mildly enlarged platelets support primary ITP. 1
• Giant platelets (approaching red blood cell size) suggest Bernard-Soulier syndrome or MYH9-related disease. 1, 4
• Leukocyte inclusion bodies indicate MYH9-related disease. 1
• Schistocytes suggest thrombotic microangiopathy (TTP/HUS/DIC), which carries >90% mortality if untreated. 1
• Immature or abnormal white cells raise suspicion for leukemia or myelodysplastic syndrome. 1

Step 4: Focused History

• Duration of thrombocytopenia: lifelong suggests inherited disorder. 3, 2
• Family history: bleeding disorders or thrombocytopenia point to familial thrombocytopenia. 3, 2
• Recent viral infections or vaccinations: typical for acute ITP. 2, 8
• Medication exposures: including over-the-counter products and herbal supplements. 1, 2
• Systemic symptoms: fever, weight loss, bone pain, or night sweats mandate bone marrow examination. 3, 1

Step 5: Physical Examination Red Flags

• Splenomegaly, hepatomegaly, or lymphadenopathy exclude primary ITP and require investigation for HIV, SLE, lymphoproliferative disorders, or chronic liver disease. 1, 2
• Skeletal abnormalities suggest thrombocytopenia-absent radius syndrome. 5
• Eczema and recurrent infections point to Wiskott-Aldrich syndrome. 1

Step 6: Mandatory Laboratory Testing (All Children)

• HIV antibody testing in children/adolescents with risk factors. 1, 2
• Direct antiglobulin test (DAT) to exclude Evans syndrome (combined autoimmune hemolytic anemia and ITP). 1, 6

Step 7: Additional Testing for Persistent Cases (>3–6 Months)

• Antinuclear antibodies (ANA) to screen for SLE. 3, 2
• Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I) for APS. 6, 2
• Quantitative immunoglobulins (IgG, IgA, IgM) to identify CVID. 3, 2
• Hepatitis C serology in adolescents with risk factors. 1, 2
• Helicobacter pylori testing (urea-breath test or stool antigen) in high-prevalence regions. 1, 2
• Bone marrow examination if not previously performed and no response to treatment. 3, 2

Step 8: Bone Marrow Examination Indications

• Age ≥10 years with chronic thrombocytopenia. 3
• Systemic constitutional symptoms (fever, weight loss, bone pain). 3, 1
• Abnormal CBC parameters beyond isolated thrombocytopenia. 3, 1
• Atypical peripheral smear findings (schistocytes, immature cells, giant platelets, inclusion bodies). 1
• Organomegaly or lymphadenopathy on physical exam. 1
• Minimal or no response to first-line ITP therapies (IVIg, corticosteroids). 1
• Thrombocytopenia recognized during the neonatal period. 7
• Failure of corticosteroid therapy. 7

Critical Pitfalls to Avoid

• Never diagnose ITP without hematopathologist review of the peripheral smear; automated counters miss pseudothrombocytopenia, giant platelets, and schistocytes. 1
• Thrombocytopenia occurring during the newborn period and failure of steroid therapy are highly predictive of secondary causes. 7
• Missing inherited thrombocytopenias such as Bernard-Soulier syndrome, which are frequently misdiagnosed as ITP due to similar clinical presentation. 4
• Overlooking secondary autoimmune causes (SLE, APS, CVID, ALPS) in children with persistent thrombocytopenia beyond 3–6 months. 3, 2
• Delaying bone marrow examination in children with atypical features, systemic symptoms, or additional cytopenias carries catastrophic mortality risk if leukemia or myelodysplastic syndrome is missed. 3, 1